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Abstract
ROLE OF THE EXOPOLYSACCHARIDE ALGINATE IN ADHERENCE TO AND
INFLAMMATION OF PULMONARY EPITHELIAL CELLS
By: Brian Edward Crossley, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of
Master of Science in Biology at Virginia Commonwealth University
Virginia Commonwealth University 2016
Major Director: Deborah A. Lebman, Associate Professor, Microbiology &
Immunology
Pseudomonas aeruginosa (PA) infections in Cystic Fibrosis (CF) patients
are not easily cleared due to the conversion from a nonmucoid to a mucoid
phenotype. Alginate is an acetylated exopolysaccharide produced by mucoid PA
that is responsible for increased resistance to antibiotics, host phagocytic killing,
and propagating biofilm formation. Understanding the interaction between PA
and host cells is critical to understanding chronic infection and inflammation in
CF. In order to investigate this, we used A549 pulmonary epithelial cells and
murine alveolar macrophages (MH-S) to examine host response to nonmucoid
versus mucoid PA infection. Adhesion assays in A549 pulmonary epithelial cells
revealed that mucoid PA mutants adhere poorly compared to their nonmucoid
counterparts. Similarly, phagocytosis assays using MH-S infected with PA
revealed that mucoid PA are increasingly resistant to phagocytosis. The alginate
acetylation mutant FRD1175 is more susceptible to phagocytic killing than
alginate+ FRD1. Adherence and phagocytosis of mucoid FRD1 was increased by
increasing the multiplicity of infection (MOI) from 50:1 to 500:1. Furthermore,
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confocal microscopy revealed that mucoid PA are inherently less inflammatory
than nonmucoid strains in both A549 and MH-S. Increasing the MOI of mucoid
FRD1 from 50:1 to 500:1 significantly increased caspase-1 activation in MH-S
but not in A549, revealing that intensity of inflammatory signaling by epithelial
cells is likely independent of increased adherence. FRD1175 infection in both
A549 and MH-S revealed that alginate acetylation plays a significant role in
reducing inflammasome activation. Western analysis revealed that PA does not
actively induce TGF-β secretion by A549 epithelial cells. Similarly, NF-κB
expression was reduced in both A549 and MH-S when infected with mucoid FRD
strains, but not PA from the PAO background, suggesting FRD strains have
accumulated additional mutations facilitating escape of inflammation. MH-S
treated with cytochalasin D to block phagocytosis were still able to activate NFκB signaling, suggesting NF-κB activation is adherence but not phagocytosis
dependent. These data increase our understanding of the various mechanisms in
which mucoid PA is able to evade host immune defenses and provides insight
into potential therapies to treat PA infections.

Introduction
Host-Pathogen Interactions
Host-pathogen interactions have been extensively studied for the better
part of a century. While primitive studies portrayed microorganisms playing a
solely parasitic role in humans, it was later discovered that microbes can play
commensal as well as mutualistic roles. When examining infection and
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occurrence, early researchers learned that the ubiquitous nature of microbes did
not directly translate to human infection and disease [3]. The interactions that
occur between disease causing microbial organisms and hosts details a long
history of virulence mechanisms and the development of a complex immune
system.
Human immunity has evolved into two distinct branches: the innate and
adaptive immune systems. Innate immunity seeks to provide a rapid response to
danger signals from potential threats through the use of phagocytic cells such as
macrophages, neutrophils, and dendritic cells. Subsequent activation of the
adaptive immune system through highly complex processes of antigen
presentation and clonal selection allow for incredibly diverse and specific
antigenic responses. Due to the lagging initiation of the adaptive immune system,
the innate immune response has been well characterized as the first, and
arguably the most critical, line of defense against internalized pathogens. This
process occurs through the activation of pattern recognition receptors (PRRs) via
binding of unique, nonhuman, peptides often termed pathogen associated
molecular patterns (PAMPs). Similarly, the innate immune system can sense
damaged human ligands released while undergoing cell death denoted damage
associated molecular patterns (DAMPs) [30, 32]

Epithelial Protection and Inflammation
In order to mobilize innate immune cells, pathogens must first breach the
body’s first layer of defense, the epithelium [24]. Epithelial cells line the body’s
mucosal organs such as the respiratory, gastrointestinal, and urinary tracts and
8

provide physical and chemical barriers to pathogens. In particular, tight junctions
physically block entry whereas lysozymes and β-defensins serve as antimicrobial
peptides naturally secreted by mucosal epithelial cells [12, 23]. Similarly,
mechanical features of these cells organize to form mucociliary elevators which
serve to physically expel bacteria from the lungs [6]. In the event that these initial
defenses fail, microbial entry and subsequent colonization may occur and cause
pathogenesis, thus activating innate, tissue-resident phagocytic cells and causing
the release of proinflammatory mediators. The onset of inflammation occurs in
order to recruit additional innate phagocytic cells to the site of infection by
increasing vascular leakage and diapedesis [24]. The process of inflammation is
highly controlled and is regulated in order to quickly resolve and return to a
homeostatic state; however, when infections are unable to be cleared, chronic
inflammation may result in damage to the host. Although inflammation has
protective and beneficial effects in acute infections, its role in chronic infections is
not fully understood [15].

Pseudomonas aeruginosa
Pseudomonas aeruginosa (PA) is a ubiquitous environmental bacterium
that exists in extremely diverse, moist environments. Clinically, it is an
opportunistic pathogen that typically infects immunocompromised or wounded
patients due to a variety of reasons, such as burns, surgery, chronic obstructive
pulmonary disease, and cystic fibrosis. The wild type PA strain PAO1 was
isolated from a wound in 1954, and is now the most common reference strain
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when examining PA [26]. Healthy individuals exposed to PA clear the bacteria
easily, without inducing noticeable inflammation. Several hypotheses have
emerged addressing how PA are increasingly adherent to CF epithelial cells,
such as ineffective mucociliary clearance of bacteria from hyperabsorption of
water [6]; however the exact mechanisms are not completely understood. Early
PA colonizing the pulmonary epithelium typically exist as non-mucoid colonies.
However, as infection persists and host defenses mobilize, the bacteria must
undergo phenotypic changes in order to survive in the harsh environment. The
conversion from non-mucoid to mucoid colonization indicates significantly poorer
prognosis for CF patients. This form of adaptation is due to a mutation in the
negative translational regulator, mucA, of the alginate biosynthetic operon. After
mutational deactivation of the anti-sigma factor mucA, the sigma factor AlgT (also
known as σ22/ AlgU) interacts with the translational regulator AlgR, thus inducing
expression of the algD operon and initiating alginate biosynthesis [11, 36].
Alginate is an acetylated exopolysaccharide formed from D-mannuronic acid and
L-guluronic acid produced that confers resistance to antibiotics, host phagocytic
killing, and increased biofilm production [45] (Figure 1). The PA strain FRD1 is a
mucoid clinical isolate obtained from a sputum sample of a chronically infected
CF patient, which constitutively expresses alginate due to the mutational
deactivation of mucA. Utilization of FRD1 provides insight to characterize the
genomic mutations responsible for increased persistence during infection.
Previously constructed mutants of both PAO1 and FRD1 provide opportunities to
further identify how the structure and expression of alginate protect PA from host
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immune defenses. PDO300, a PAO1 mutant, has a constructed mucA mutation,
which allows for the overproduction of alginate; while FRD1131 is a FRD1 mutant
with the transposon algD:: Tn501-33, inserted just before the first gene, algD,
within the alginate promoter; therefore, blocking synthesis of alginate. Similarly,
FRD1175 and FRD462 are FRD1 mutants with acetylation and epimerization
defects, respectively. Alginate acetylation occurs at the C2-C3 hydroxyl
substituents on mannuronic acid residues, and confers resistance to opsonic
phagocytosis through the blockade of receptors capable of binding complement
opsonins [38]. FRD1175 is unable to O-acetylate alginate due to a constructed
mutation on algF, which is one of three products within the alginate synthesis
operon required for acetylation, alongside algI and algJ [13, 38]. Alginate
epimerization is mediated by AlgG, a C5 epimerase and occurs through
subsequent conversion of 20-40% of mannuronate residues to form linkages
between alternating D-mannuronate and L-guluronate molecules [44]. These
epimerase linkages give rise to increasingly viscous and gelation properties of
alginate, further increasing PA ability to evade host defenses [44]. FRD426 has
a constructed mutation in AlgG, which prevents C-5 epimerase from converting
mannuronate residues to linkages between mannuronate and guluronate. By
examining host interactions with FRD1175 and FRD426, we can evaluate the
effects of the structure of alginate, beyond simply its expression. PA strains used
in this study are outlined in Table 1.
Virulence factor expression varies greatly between acute and chronic PA
infections. Acute PA infections invoke a variety of inflammatory molecules in
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order to actively establish infection, whereas chronic PA infections rely heavily on
the down regulation of these same virulence factors [14]. Acute infections are
facilitated via adhesion molecules such as flagella, type 4 pili, and
lipopolysaccharide (LPS). Once PA have successfully attached to host
epithelium, activation of the type 3-secretion system (T3SS) further exacerbates
cytotoxic effects on the host through the injection of effector molecules ExoU,
ExoS, ExoT, ExoY [14, 20]. Similarly, a multitude of proteases secreted by PA
enable colonization through the disruption of tight junctions and degradation of
host lung proteins [14, 25].
During the course of chronic infection, PA undergo a variety of adaptive
mutations that increase the likelihood of survival in the presence of host immune
cells. Most notably, the ability of chronic PA to undergo a conversion from nonmucoid to mucoid phenotype allows for the cultivation of antibiotic resistant
biofilms. In doing so, it is common for mucoid PA to down regulate many
virulence genes such as components of the T3SS, LPS side chains, and flagellin,
the main structural component of flagella. This inverse relationship between
expression of flagella and T3SS is mediated via AlgT. Flagella are potent
activators of host immunity through recognition and binding to TLR5, causing
increased inflammatory signaling and mobilization of innate immune cells [14,
33]. Similarly, T3SS effector molecules enhance host recognition of PA through
NAIP (NLR family of apoptosis inhibitor proteins) sensors and cause subsequent
formation of the inflammasome complex.
Cystic Fibrosis
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Cystic Fibrosis (CF) is an autosomal recessive disorder resulting from an
accumulation of mutations in the gene regulating the Cystic Fibrosis
Conductance Transmembrane Regulator (CFTR). These mutations cause
chloride ion transporters to become defective in epithelial cells, leading to
increased secretion of chloride in sweat, hyperabsorption of sodium, infertility,
and chronic pulmonary disease [19, 39, 43]. While CF typically affects organs
throughout the body, the major cause of morbidity and mortality in affected
patients is deterioration of lung function due to chronic inflammation, remodeling
of epithelial cells, decreased expiration rates, and chronic infection from PA [9,
34]. Furthermore, the pathophysiology of CTFR defects in epithelial cells extends
beyond chloride ion transport. Notably, this mutation has been shown to affect a
multitude of other processes such as vesicle trafficking and increased expression
of a variety of cytokines which modulate inflammation, such as IL-8 and IL-10 [2,
8]. Despite this, it has been hypothesized that lungs in infants and young CF
patients are inherently uninflamed until actual infections occur [1], reinforcing the
hypothesis that infection precedes inflammation. Increased neutrophil presence
in CF patients compared to normal patients has also been described to
exacerbate the inflammatory response, possibly due to increased release of IL-8
by CF epithelial cells [1, 8]. It has been suggested that excessive influx of
neutrophils into the airway is an ineffective immune response to PA infections
within CF patients.
Inflammatory Response and Activation of the Caspase-1 Inflammasome in
the CF lung.
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The initial immune response to infections within the lung involves
pulmonary epithelial cells, neutrophils, and alveolar macrophages, which in turn
secrete a variety of cytokines controlling the inflammatory response [10]. These
cytokines act on a variety of receptors and cell transcription factors, such as
Nuclear Factor-κB (NF-κB). Ligand binding to TLRs activates the NF-κB signaling
canonical signaling pathway, which triggers subsequent activation of a wide
range of downstream kinases that in turn lead to cell survival, proliferation, and
cytokine production. [27]. The effects of proinflammatory cytokines such as IL-1β,
which are readily secreted by alveolar macrophages and epithelial cells, can be
reversed by anti-inflammatory cytokines, such as TGF-β [31].
Upon recognition of foreign ligands via PAMPs, mobilized innate immune
cells boast a variety of defenses. Most notably, monocytes and macrophages
secrete proinflammatory mediators, which exhibit one of two fates: activation of
the inflammasome, or encouragement of apoptotic cell death pathways [7, 29].
The caspase-1 inflammasome exists as a multimeric protein complex composed
of a variety of PRRs including the NLR family (Nod-like receptor), NAIP sensors,
and pro-caspase [16]. The sensing of different bacterial ligands triggers the
recruitment and formation of different inflammasome proteins. With respect to
bacterial infections, it has been determined that the NLRC4 inflammasome is
stimulated by bacterial flagellin and components of the T3SS [16, 33]. These
bacterial products are initially sensed by NAIP receptors before allowing
downstream NLRC4 to directly recruit caspase-1 activators via its CARD domain,
which in turn drives antimicrobial responses [42]. Activated caspase-1 results in
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the cleavage of pro-IL-1β and subsequent recruitment of neutrophils to amplify
bacterial clearance [33, 42].
Specific Aims of This Project
Understanding the interaction between PA and host cells is critical to fully
understanding the pathogenesis of CF. In order to examine these interactions,
we sought to determine how the alteration in PA accompanying chronic infection
contributes to the inflammasome and the surrounding environment. Specifically,
we examined how host response cytokine production is affected by various
mucoid transformations in addition to alterations in cell signaling pathways. In
addition, we determined how mucoid conversion and alginate expression alters
the interaction between epithelial cells and PA. Although studies have shown that
adaptations in PA clearly inhibit innate immunity, the mechanisms within the
inflammasome due to these changes are poorly understood. By further
understanding the host-pathogen interactions that alter the inflammatory
response, it could shed light in the treatment of chronic infection and lead to a
better understanding of potential therapies for cystic fibrosis patients.
Materials & Methods
A549 Culture
A549 epithelial cells from a human lung adenocarcinoma were cultured in
complete F12-HAMS (Hyclone) supplemented with 10% FBS (Atlanta
Biologicals), 1% penicillin and streptomycin, and 1% L-glutamine. Cells were
monitored for confluency and passed every 3-4 days. Fresh cultures stored were
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stored in a -80oC freezer were thawed every 3-4 months. Prior to use, cells were
counted using a hemocytometer or Bio-Rad Automated Cell Counter before
plating.
Macrophage Culture
Murine Alveolar Macrophages (MH-S) were cultured in complete RPMI
(Gibco) supplemented with 10% FBS (Atlanta Biologicals), 1% penicillin and
streptomycin, and 1% L-glutamine. Cells were monitored for confluency and
passed every 3-4 days. Fresh cultures were stored in a -80oC freezer were
thawed every 3-4 months. Prior to use, cells were counted using a
hemocytometer or Bio-Rad Automated Cell Counter before plating.
Pseudomonas aeruginosa Growth Conditions
All PA strains were newly streaked from frozen stocks and grown on solid
Luria-Bertani (LB) agar plates 3 days prior to use. Following initial growth on agar
plates, single colonies were isolated and diluted in LB liquid broth at 37oC with
shaking overnight.
Pseudomonas aeruginosa Strains
Strains are outlined in Table 1. FRD1 is a clinical isolate from a sputum
from a CF patient. FRD1 actively produces alginate due to a mucA mutation
which fails to prevent σ22 from binding to the promoter and initiating transcription.
FRD1131 is a FRD1 mutant with the transposon, algD:: Tn501-33, inserted just
before the first gene, algD, within the alginate promoter; therefore, blocking
synthesis of alginate. FRD462 is a FRD1 algG mutant with a defective C5
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epimerase rendering it unable to form complete alginate, instead only forming Dmannuronate. FRD1175 is a FRD1 algF mutant, which is unable to O-acetylate
D-mannuronate. PAO1 is the wild type (WT) from a clinical burn
wound. PDO300 is a PAO1 mutant with a constructed mucA22 mutation,
causing it to readily produce alginate.
Epithelial Cell Adherence Assay
2x105 A549 epithelial cells were plated in complete F12-HAMS (Hyclone)
in 12-well plates 24 hours before infection. Cells were washed once with warm
serum free/ antibiotic free F12-HAMS 6 hours prior to infection. Overnight
cultures of Pseudomonas aeruginosa were diluted 1:50 and grown for 4 hours
until mid-log phase (0.8 OD/600nm). A549 cells were infected at a MOI of 50:1 or
500:1 and incubated at 37oC, 5% CO for 1 hour. A549 cells were washed three
2

times with cold PBS and then lysed with 0.1% Triton (Sigma). Cell lysate was
then collected by scraping and underwent 1:10 serial dilutions before plating on
LB agar plates. Plates were incubated at 37oC overnight. Colonies were counted
the following day to determine Colony Forming Units (CFU).

Phagocytosis Assay with Gentamicin Protection
2x105 murine alveolar macrophages (MH-S) were plated in complete
RPMI (Gibco) in 12-well plates 24 hours before infection. Cells were washed
once with warm serum free/ antibiotic free RPMI 6 hours prior to infection.
Overnight cultures of Pseudomonas aeruginosa were diluted 1:50 and grown for
4 hours to mid-log phase (0.8 OD/600nm). MH-S cells were infected at a MOI of
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50:1 or 500:1 and incubated at 37oC, 5% CO for 30 minutes. MH-S cells were
2

washed twice with warm RPMI, and then gentamicin was added to each well at a
concentration of 2 mg/ml and then re-incubated at 37oC, 5% CO for 30 minutes.
2

MH-S cells were washed twice with cold PBS and then lysed with 0.25% SDS.
Cell lysate was then collected by scraping and underwent 1:10 serial dilutions
before plating on LB agar plates. Plates were incubated at 37oC overnight.
Colonies were counted the following day to determine Colony Forming Units
(CFU).
Fluorescent Microscopy- Caspase-1
4x105 A549 or MH-S cells were plated in complete cell line media in 27mm
Glass Base Dishes (Thermo Sci) 24 hours prior to infection. Cells were washed
once with serum free/ antibiotic free media 6 hours prior to infection. Overnight
cultures of Pseudomonas aeruginosa were diluted 1:50 and grown for 4 hours
until mid-log phase (0.8 OD/600nm). A549 or MH-S cells were infected at a MOI
of 50:1 or 500:1 and incubated at 37oC, 5% CO for 1 hour. A549 or MH-S cells
2

were washed twice with cold PBS and replaced with 300 µl warm cell line media.
FLICA reagent was prepared according to the manufacturer’s instructions
(Invitrogen). 10 µl FLICA reagent was added per 300 µl cell culture and then
incubated at 37oC, 5% CO for 1 hour. A549 and MH-S cells were washed once
2

with warm cell line media and then incubated with 1 µM Hoechst 33342 Nuclear
Stain (Invitrogen) at 37oC, 5% CO for 10 minutes. A549 and MH-S cells were
2

fixed with 4% paraformaldehyde (Affymetrix) in PBS for 15 minutes.
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Paraformaldehyde was removed and replaced with cold PBS prior to viewing on
a Zeiss LSM 710 at 40x or 63x magnification.
Western Blotting Analysis
2x105 A549 or MH-S cells were plated in complete cell line media in 6 well
plates 24 hours prior to infection. Overnight cultures of Pseudomonas aeruginosa
were diluted 1:50 and grown for 4 hours to mid-log phase (0.8 OD/600nm). A549
or MH-S cells were infected at a MOI of 50:1 or 500:1 and incubated at 37oC, 5%
CO for 1 hour. A549 or MH-S cells were washed twice with cold PBS. A549 or
2

MH-S cells were lysed with 70 µl RIPA buffer (Thermo Sci) containing 5 µl
protease inhibitor (Thermo Sci), 5 µl phosphatase inhibitor (Thermo Sci), and 5 µl
PMSF (Thermo Sci). Cell lysate was scraped and harvested before being
centrifuged at 4oC for 15 minutes. Supernatants were collected and stored at 80oC for further analysis. Protein concentrations were determined using a
Bradford Protein Assay. 20 µg of protein was separated on an 8%, 10% or 12%
polyacrylamide gel in Tris-Glycine buffer at 175 volts for 70 minutes. Proteins
were then transferred onto PVDF membranes using a Semidry Transfer cell in
Towbin (Tris-Glycine-SDS) buffer at 25 volts for 30 minutes. The membranes
were allowed to dry for 15 minutes before being blocked in 5% Nonfat Dry Milk
(NFDM) in TBS containing 0.01% Tween for 45 minutes. Various rabbit primary
antibodies (Cell Signaling) were diluted 1:1000 in 5% NFDM in TBS/Tween and
were allowed to attach at 4oC with gentle shaking overnight. The membranes
were washed three times with TBS/Tween for 10 minutes each and then labeled
with an anti-rabbit secondary antibody (Cell Signaling) diluted 1:10000 in 2.5%
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NFDM in TBS/Tween. Membranes were then washed four times in TBS/Tween
for 15 minutes each. Perkin Elmer chemiluminescence substrates were added to
membranes for one minute before being exposed to x-ray film. When stripping in
order to tag membranes with various primary antibodies, stripping buffer (2-beta
mercaptoethanol, 10% SDS, Tris 6.8M) was added to membranes at 55oC with
rotation for 30 minutes. Membranes were then washed 5 times in TBS/Tween for
5 minutes each before being re-blocked.
Results
Effects of mucoidy on lung epithelial adherence of PA.
The current dogma of activating immunity begins with adherence and
subsequent breachment of the epithelium, where pathogens are encountered by
innate immune cells [24]. In cystic fibrosis, opportunistic PA successfully
colonizes the lung epithelium in a non-mucoid state. However, due to
increasingly harsh environmental conditions, mutations give rise to mucoid
colonies, characterized by the production of exopolysaccharide alginate. In order
to address mucoidy effects on epithelial adherence, A549 lung epithelial cells
were infected at a multiplicity of infection (MOI) of 50:1 or 500:1 for 1 hour. The
data showed that mucoid PA were unable to adhere to A549 epithelial cells as
well as non-mucoid strains. After increasing the MOI of FRD1 from 50:1 to 500:1,
in order to achieve equal adherence to a non-mucoid strain, FRD1131, the
number of FRD1 adhering to A549 epithelial cells was significantly
increased (Figure 2). These data suggest that increasing the multiplicity of
infection of PA can increase overall adherence.
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Mucoidy effects on phagocytosis of PA by alveolar macrophages.
In cystic fibrosis, research has shown that the colonization of mucoid PA is
not easily cleared by host immune cells [45]. Because alveolar macrophages
serve as one of the primary host defenses of lung infections, we investigated the
effects of mucoidy on phagocytosis. Murine alveolar macrophages were infected
with various PA strains at an MOI of 50:1 or 500:1 for 30 minutes. Our data
suggests that mucoid PA strains are phagocytosed significantly less than nonmucoid strains. After increasing the MOI of FRD1 from 50:1 to 500:1, the number
of FRD1 being phagocytosed was significantly increased. These data also
suggest that alginate acetylation, but not alginate epimerization, decreases the
ability of alveolar macrophages to phagocytose mucoid PA (Figure 3). These
data further support previous studies detailing the protective nature of substituted
acetyl groups by blocking access of opsonins from attaching to PA surface [38].
Mucoidy effects on inflammasome activation in A549 epithelial cells and
murine alveolar macrophages.
Inflammasome activation plays a critical role in the maturation of proinflammatory mediators in order to amplify bacterial clearance [33, 42]. In order
to assess the effects of mucoidy on inflammasome activation, we quantified total
caspase-1 activation following infection with various PA strains in A549 epithelial
cells and murine alveolar macrophages for 1 hour via confocal microscopy. Our
data suggests that mucoid PA significantly decreases caspase-1 signaling
compared to non-mucoid strains in A549 epithelial cells (Figure 4) and alveolar
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macrophages (Figure 5). These data suggest that mucoid PA are inherently less
inflammatory than nonmucoid strains.
Increasing multiplicity of infection in mucoid PA increased caspase-1
activation in murine alveolar macrophages, but not in A549 epithelial cells.
Our previous data showed that the amount of mucoid PA adhering to lung
epithelial cells and alveolar macrophages was significantly less than the amount
of non-mucoid colonies adhering. In order to determine if increased adherence
led to increased caspase-1 activation, we increased the multiplicity of infection of
FRD1 from 50:1 to 500:1, and then quantified caspase-1 activation following
infection with various PA strains for 1 hour via confocal microscopy. These data
suggest that bacterial adherence does not translate directly to caspase-1
activation in A549 epithelial cells (Figure 6). In contrast, increased MOI of FRD1
significantly increased the amount of caspase-1 activation in murine alveolar
macrophages (Figure 7).
Alginate acetylation, but not alginate epimerization, decreased caspase-1
activation in A549 epithelial cells and murine alveolar macrophages.
Since our data above suggested that macrophages exhibited improved
phagocytosis of non-acetylated, mucoid PA, we examined the effects of alginate
acetylation and epimerization on activation of caspase-1 in A459 epithelial cells
and murine alveolar macrophages via confocal microscopy. These data suggest
that non-acetylated, mucoid bacteria activate caspase-1 significantly more than
acetylated, mucoid bacteria in A549 epithelial cells (Figure 8) and murine
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alveolar macrophages (Figure 9). Alginate epimerization did not play a role in
caspase-1 activation.
PA did not induce TGF-β secretion in A549 epithelial cells.
TGF-β acts as an anti-inflammatory cytokine, and is primarily produced in
the lungs by alveolar macrophages and epithelial cells [31]. In order to assess if
mucoidy was responsible for inducing anti-inflammatory signaling in epithelial
cells, western analysis for phosphorylated SMAD2/3 was performed following
infection with various PA strains at an MOI of 50:1 or 500:1 for 1 hour. These
data suggest that infection with PA does not induce TGFβ secretion in A549
epithelial cells, regardless of alginate expression (Figure 10).
Analyzing NF-κB expression in A549 epithelial cells and murine alveolar
macrophages after infection with PA.
Our data above suggested that mucoid strains of PA were generally
reduced in the amount of caspase-1 activation with both A549 epithelial cells and
murine alveolar macrophages. In order to further assess the ability of mucoid and
nonmucoid PA to induce inflammation, western analysis for phosphorylated NFκB (p65) was performed following infection with various PA strains at an MOI of
50:1 or 500:1 for 1 hour in A549 epithelial cells. Phosphorylation of p65 was only
slightly elevated in PA strains that were of the PAO1 background, compared to
the FRD strains in A549 epithelial cells. These data also suggest that mucoidy
and MOI may play larger roles in activating NF-κB in the FRD strains (Figure 11).
Similarly, phosphorylation of p65 was assessed in resting and cytochalasin D
treated murine alveolar macrophages following infection with various PA strains
23

at an MOI of 50:1 or 500:1 for 1 hour. Phosphorylated p65 was slightly
suppressed in FRD1 and FRD462 infected alveolar macrophages, compared to
the other PA strains (Figure 12). Cytochalasin D treated alveolar macrophages
did not seem to inhibit p65 phosphorylation, suggesting that phagocytosis of PA
was not necessary in order to activate inflammatory signaling (Figure 12).
Analyzing Caspase-1 cleavage in A549 epithelial cells after infection with
PA.
Our data above collected by confocal microscopy suggested that mucoid
PA decreased caspase-1 activation in A549 epithelial cells. In order to confirm
this finding, western analysis for cleaved caspase (p20) was performed following
infection with various PA strains at an MOI of 50:1 or 500:1 for 1 hour. Levels of
p20 were decreased in Alg+ FRD1 compared to the other FRD strains. These
data also suggested that increasing the MOI of FRD1 from 50:1 to 500:1
increased the amount of cleaved caspase, differing slightly from our previous
results in Figure 6 (Figure 13).
DISCUSSION
Chronic PA infections have are a major cause of morbidity and mortality in
CF patients [18, 21]. The inherent difficulties of CF patients to clear excessive
mucus, in addition to the adaptive abilities of PA allow for persistent infections;
this is also partially due to improved resistance to many antibiotics [18]. A major
pathoadaptive change in PA within the CF lung involves the transition from a
non-mucoid to the mucoid phenotype, often characterized by the deactivation
mutation within the translational regulator encoded by mucA [45]. This mutation
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results in excessive production of the exopolysaccharide alginate, which confers
resistance to many host defense factors as well as aiding biofilm formation and
protection [28]. Our lab has previously characterized the role of alginate in the
inhibition of macrophage phagocytosis [40], but the role of alginate in adherence
and inflammasome activation in epithelial cells remained unclear. In order to
address these issues, we expanded our studies to include A549 alveolar
epithelial cells based on the paradigm of innate activation of inflammation and
implications in previous studies [18]. Parallel studies with A549 alveolar epithelial
cells and murine alveolar macrophages infected with various PA strains were
used in order to characterize the role of alginate in adherence and activation of
inflammation in pulmonary epithelial cells and macrophages.
In this study, we began to unravel questions regarding the ability of PA to
escape host immune responses. While previous studies have often compared
various PA strains at the same MOI, we showed that by increasing the MOI of a
mucoid strain (FRD1), similar adherence and phagocytosis could be achieved to
a nonmucoid mutant of the same strain (FRD1131). By eliminating the effect of
reduced adherence, we could more effectively compare the amount of
inflammatory signaling between nonmucoid and mucoid PA strains. Our data
revealed that caspase-1 signaling in A549 epithelial cells did not significantly
increase when infected with FRD1 at an MOI of 50:1 or 500:1. This result
suggested that the CF clinical isolate, FRD1, is inherently less inflammatory than
its nonmucoid mutant. This suggests that the inverse relationship between
alginate and T3SS expression plays a significant role in dampening host
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immunity [41]. We hypothesized that alginate expression in FRD1 may result in a
significant physical barrier thick enough to block entry of the T3SS needle into
host cytoplasm. Similarly, the repression of T3SS in clinical isolates has been
shown to reduce virulence, and allow PA the ability to escape inflammation [22,
46]. While the exact mechanism is unknown, the maturation of chronic PA from
the accumulation of mutations may confer increased resistance to host immunity
through repression of T3SS rather than relying on T3SS effector molecules
ExoT, ExoU, and ExoS to block the maturation of caspase-1 [17]. Similarly, the
repression of flagellum expression has shown to dampen host immunity.
Previous reports suggest that loss of flagellar motility, independent of flagellar
expression, reduces IL-1β secretion and caspase-1 activation in macrophages
Through the loss of flagellar motility, decreased cell surface interactions with host
cell receptors may play a role in escaping immune cell function [37]. This
conclusion aligns with results of this study, suggesting that decreased adhesion
serves as an important mechanism for bacterial persistence in the CF lung. In
murine alveolar macrophages, slight increases in caspase-1 signaling were seen
when increasing the MOI of FRD1 from 50:1 to 500:1, but remained significantly
less than that of Alg- FRD1131. This result may be due to increased
phagocytosis and internalization of FRD1 bacteria, thus leading to the increased
activation of caspase-1.
Alginate in PA exists as an ester linked polymer of D-mannuronate and Lguluronate, which confers formation of many O-acetyl groups on the C-2 and C-3
acid residues of mannuronic acid, thus providing increased virulence [38]. O-
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acetylation of alginate has been shown to contribute to biofilm formation and its
structural integrity [12]. In this study, we evaluated the effects of alginate
structure in activating the inflammasome. Our data did not reveal any significant
increases in non-acetylated PA (FRD1175) adhesion to A549 epithelial cells, but
did show increased caspase-1 activation in both A549 epithelial cells and murine
alveolar macrophages. A previous study revealed how alginate hydroxyl linkages
dampen opsonic phagocytosis through the blockade of unsubstituted hydroxyl
residues capable of binding complement proteins to the bacterial surface [38].
This could help explain the increased caspase-1 activation seen in both A549
and MH-S cells when infected with non-acetylated, mucoid PA. Western blot
analysis of phosphorylated NF-κB showed slightly increased activity in both cell
lines when infected with non-mucoid or non-acetylated FRD strains. This result
suggests the ability to interact with aggregated host cell receptors is necessary to
activate NF-κB. Previous reports have suggested that alginate expression and
presence is capable of altering host responses not seen in motile PA strains, in
addition to the blockade of TLR-2,-4, and-5, rendering airway epithelial cells
unable to activate NF-κB [5] [35]. Similarly, the increased activation of NF-κB
seen in non-acetylated FRD1175 alginate may be due to the loss of alginate
structural integrity, thus allowing host TLRs to induce downstream signaling. The
treatment of MH-S macrophages with 10 µM Cytochalasin D did not affect the
activity of phosphorylated NF-κB, revealing that internalization of TLRs was not
necessary to initiate downstream signaling.
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In summary, these data increased our understanding of the various
mechanisms by which mucoid PA is able to evade host immune defenses. The
ability of PA to escape inflammation in A549 alveolar epithelial cells is dependent
on the strain background, alginate expression, and alginate structure. These data
reveal that further investigation of alginate is needed, and supports that targeting
alginate acetylation as a valid therapeutic target.
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Tables & Figures

Table 1: Description of Bacterial Strains
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Figure 1: A. Structure of Alginate. B. Alginate Biosynthetic Operon [4]
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Figure 2: Adherence of P. aeruginosa to A549 Epithelial Cells. A549 cells were plated at
5
2x10 in complete F12-HAMS 24 hours prior to infection. Overnight cultures of Pseudomonas
aeruginosa were diluted 1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). A549
o
cells were infected at a MOI of 50:1 or 500:1 and incubated at 37 C, 5% CO2 for 1 hour. Cell
o
lysate was collected plated on LB agar plates. Plates were stored at 37 C overnight. Colonies
were counted the following day to determine Colony Forming Units (CFU). Statistical analysis
was performed by ANOVA followed by Tukey’s test. *P<0.05, **P<0.01, ***P<0.001,
****P<0.0001, ns: not significant.
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Figure 3: Phagocytosis of P. aeruginosa by Murine Alveolar Macrophages. MH-S cells were
5
plated at 2x10 in complete RPMI 24 hours prior to infection. Overnight cultures of Pseudomonas
aeruginosa were diluted 1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). MH-S
o
cells were infected at a MOI of 50:1 or 500:1 and incubated at 37 C, 5% CO2 for 30 minutes.
o
Gentamicin was added to each well at a concentration of 2mg/ ml and then re-incubated at 37 C,
5% CO2 for 30 minutes. Cell lysate was collected plated on LB agar plates. Plates were stored at
o
37 C overnight. Colonies were counted the following day to determine Colony Forming Units
(CFU). Statistical analysis was performed by ANOVA followed by Tukey’s test. *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001, ns: not significant.
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Figure 4: Caspase-1 Activation in A549 epithelial cells post infection with P. aeruginosa.
5
4x10 A549 cells were plated in complete F12-HAMS in 27mm Glass Base Dishes 24 hours prior
to infection. Complete F-12 HAMS was washed once with serum free/ antibiotic free media 6
hours prior to infection. Overnight cultures of Pseudomonas aeruginosa were diluted 1:50 and
grown for 4 hours until mid-log phase (0.8 OD/600nm). A549 cells were infected at a MOI of 50
o
and incubated at 37 C, 5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached for 1 hour
before fixing cells and viewing on a Zeiss Laser Scanning Microscope (LSM710). (A)
+
Quantification of percentage of caspase-1 cells following infection with indicated PA strain. (B)
A549 cells were uninfected (i), infected with FRD1 (ii), FRD1131 (iii), PDO300 (iv), or WT PAO1
(v). Cells were stained for cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images
were taken at 63x magnification. Minimum of 100 cells were counted for quantification. Data are a
sum of triplicate experiments. Statistical analysis was performed by ANOVA followed by Tukey’s
test. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns: not significant.
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Figure 5: Caspase-1 Activation in Murine Alveolar Macrophages post infection with
5
P.aeruginosa. 4x10 MH-S cells were plated in complete RPMI in 27mm Glass Base Dishes 24
hours prior to infection. Complete RPMI was washed once with serum free/ antibiotic free media 6
hours prior to infection. Overnight cultures of PA were diluted 1:50 and grown for 4 hours until
o
mid-log phase (0.8 OD/600nm). MH-S cells were infected at a MOI of 50 and incubated at 37 C,
5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached for 1 hour before fixing cells and
viewing on a Zeiss Laser Scanning Microscope (LSM710). (A) Quantification of percentage of
+
caspase-1 cells following infection with indicated PA strain. (B) MH-S were uninfected (i),
infected with FRD1 (ii), FRD1131 (iii), PDO300 (iv), or WT PAO1 (v). Cells were stained for
cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images were taken at 63x
magnification. Minimum of 100 cells were counted for quantification. Data are sum of triplicate
experiments. Statistical analysis was performed by ANOVA followed by Tukey’s test. *P<0.05,
**P<0.01, ***P<0.001, ****P<0.0001, ns: not significant.
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Figure 6: Caspase-1 Activation in A549 epithelial cells post infection with varying P.
5
aeruginosa at various MOI. 4x10 A549 cells were plated in complete F12-HAMS in 27mm
Glass Base Dishes 24 hours prior to infection. Complete F-12 HAMS was washed once with
serum free/ antibiotic free media 6 hours prior to infection. Overnight cultures of PA were diluted
1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). A549 cells were infected at a
o
MOI of 50 and incubated at 37 C, 5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached
for 1 hour before fixing cells and viewing on a Zeiss Laser Scanning Microscope (LSM710). (A)
+
Quantification of percentage of caspase-1 cells following infection with indicated PA strain. (B)
A549 cells were uninfected (i), infected with FRD1 (ii), FRD1-MOI 500 (iii), or FRD1131 (iv). Cells
were stained for cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images were taken
at 63x magnification. Minimum of 100 cells were counted for quantification. Data are sum of
triplicate experiments. Statistical analysis was performed by ANOVA followed by Tukey’s test.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns: not significant.
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Figure 7: Caspase-1 Activation in Murine Alveolar Macrophages post infection with P.
5
aeruginosa at various MOI. 4x10 MH-S cells were plated in complete RPMI in 27mm Glass
Base Dishes 24 hours prior to infection. Complete RPMI was washed once with serum free/
antibiotic free media 6 hours prior to infection. Overnight cultures of PA were diluted 1:50 and
grown for 4 hours until mid-log phase (0.8 OD/600nm). MH-S cells were infected at a MOI of 50
o
and incubated at 37 C, 5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached for 1 hour
before fixing cells and viewing on a Zeiss Laser Scanning Microscope (LSM710). (A)
+
Quantification of percentage of caspase-1 cells following infection with indicated PA strain. (B)
MH-S were uninfected (i), infected with FRD1 (ii), FRD1-MOI 500 (iii), or FRD1131 (iv). Cells
were stained for cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images were taken
at 63x magnification. Minimum of 100 cells were counted for quantification. Data are sum of
triplicate experiments. Statistical analysis was performed by ANOVA followed by Tukey’s test.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns: not significant
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Figure 8: Caspase-1 Activation in A549 epithelial cells post infection with P. aeruginosa
5
alginate structural mutants. . 4x10 A549 cells were plated in complete F12-HAMS in 27mm
Glass Base Dishes 24 hours prior to infection. Complete F-12 HAMS was washed once with
serum free/ antibiotic free media 6 hours prior to infection. Overnight cultures of PA were diluted
1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). A549 cells were infected at a
o
MOI of 50 and incubated at 37 C, 5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached
for 1 hour before fixing cells and viewing on a Zeiss Laser Scanning Microscope (LSM710). (A)
+
Quantification of percentage of caspase-1 cells following infection with indicated PA strain. (B)
A549 cells were uninfected (i), infected with FRD1 (ii), FRD1131 (iii), FRD462 (iv), or FRD1175
(v). Cells were stained for cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images
were taken at 63x magnification. Minimum of 100 cells were counted for quantification. Data are
sum of triplicate experiments. Statistical analysis was performed by ANOVA followed by Tukey’s
test. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns: not significant.
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Figure 9: Caspase-1 Activation in Murine Alveolar Macrophages post infection with P.
5
aeruginosa alginate structural mutants. 4x10 MH-S cells were plated in complete RPMI in
27mm Glass Base Dishes 24 hours prior to infection. Complete RPMI was washed once with
serum free/ antibiotic free media 6 hours prior to infection. Overnight cultures of PA were diluted
1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). MH-S cells were infected at a
o
MOI of 50 and incubated at 37 C, 5% CO2 for 1 hour. Caspase probe (Invitrogen) was attached
for 1 hour before fixing cells and viewing on a Zeiss Laser Scanning Microscope (LSM710). (A)
+
Quantification of percentage of caspase-1 cells following infection with indicated PA strain. (B)
MH-S were uninfected (i), infected with FRD1 (ii), FRD1131 (iii), FRD462 (iv), or FRD1175 (v).
Cells were stained for cleaved caspase-1 (FAM-FLICA) and DNA (Hoechst 33342). Images were
taken at 63x magnification. Minimum of 100 cells were counted for quantification. Data are sum of
triplicate experiments. Statistical analysis was performed by ANOVA followed by Tukey’s test.
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, ns: not significant
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Figure 10: Western Analysis of TGF-β activation in A549 epithelial cells. 2x10 A549 cells were plated in
F-12 HAMS in 6 well plates 24 hours prior to infection. Overnight cultures of Pseudomonas aeruginosa were
diluted 1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). A549 cells were infected at a MOI of
o
50:1 or 500:1 and incubated at 37 C, 5% CO2 for 1 hour. Lysates were separated on 10% polyacrylamide gel
and exposed to film.

5

Figure 11: Western Analysis of NF-κB activation in A549 epithelial cells. 2x10 A549 cells were plated in F12 HAMS in 6 well plates 24 hours prior to infection. Overnight cultures of Pseudomonas aeruginosa were
diluted 1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). A549 or MH-S cells were infected at a
o
MOI of 50:1 or 500:1 and incubated at 37 C, 5% CO2 for 1 hour. Lysates were separated on 10% polyacrylamide
gel and exposed to film.
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Figure 12: Western Analysis of NF-κB activation in Murine Alveolar Macrophages. 2x10 MHS cells
were plated in RPMI in 6 well plates 24 hours prior to infection. Overnight cultures of Pseudomonas
aeruginosa were diluted 1:50 and grown for 4 hours until mid-log phase (0.8 OD/600nm). MH-S cells were
o
infected at a MOI of 50:1 or 500:1 and incubated at 37 C, 5% CO2 for 1 hour. Lysates were separated on
10% polyacrylamide gel and exposed to film.

5

Figure 13: Western Analysis of Caspase-1 in A549 epithelial cells. 2x10 A549 cells were
plated in F-12 HAMS in 6 well plates 24 hours prior to infection. Overnight cultures of
Pseudomonas aeruginosa were diluted 1:50 and grown for 4 hours until mid-log phase (0.8
o
OD/600nm). A549 cells were infected at a MOI of 50:1 or 500:1 and incubated at 37 C, 5% CO2
for 1 hour. Lysates were separated on 12% polyacrylamide gel and exposed to film.
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